Welcome to our dedicated page for Affirm Holdings SEC filings (Ticker: AFRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Digging through Affirm’s BNPL credit metrics, delinquency tables, and securitization details can take hours. Each Affirm Holdings 10-K or 10-Q packs dense disclosures on loan performance, funding costs, and merchant concentration—information essential to valuing a fintech lender but difficult to locate quickly.
Stock Titan solves that problem. Our AI reads every new document the moment it hits EDGAR, then delivers Affirm SEC filings explained simply. Compare charge-offs quarter over quarter with one click in the Affirm quarterly earnings report 10-Q filing, or see an Affirm annual report 10-K simplified summary that highlights risk-factor changes and BNPL regulatory updates. Need transaction alerts? We stream Affirm Form 4 insider transactions real-time, letting you track Affirm executive stock transactions Form 4 without sifting through PDFs. Even sudden events—new bank credit lines or securitization upsizes—appear instantly via our Affirm 8-K material events explained feed.
Whether you’re screening for Affirm insider trading Form 4 transactions, running an Affirm earnings report filing analysis, or reviewing the Affirm proxy statement executive compensation table, our platform keeps you ahead. Real-time updates, AI-powered summaries, and expert context mean you spend less time reading and more time making decisions—understanding Affirm SEC documents with AI instead of drowning in them.
Affirm Holdings, Inc. (AFRM) Form 4 summary: On 08/18/2025, Robert O'Hare, CFO, reported transactions effected under a Rule 10b5-1 plan adopted December 6, 2024. The Form 4 shows acquisitions and a subsequent sale: 10,414 shares of Class A common stock were reported acquired at $49 and 991 shares acquired at $57.59, followed by a sale of 11,405 shares at $80, leaving 0 shares of Class A common stock beneficially owned on a non-derivative basis. The filing also discloses stock options: a $49 option covering 10,414 shares and a $57.59 option covering 991 shares; the filing reports 20,829 and 29,071 derivative securities beneficially owned following the transactions, respectively. Vesting schedules and exercise conditions are described in the explanations.
Michael Linford, Chief Operating Officer of Affirm Holdings (AFRM) reported transactions on 08/18/2025 showing he exercised 10,800 stock options at an exercise price of $5.39 per share and immediately sold 10,800 Class A shares at $80.00 per share under a Rule 10b5-1 trading plan adopted on February 14, 2025. After these transactions he beneficially owned 109,840 Class A shares directly and held options/rights such that his total beneficial position related to Class A common stock was 718,070 shares (including unvested option shares). The Form 4 was signed by attorney-in-fact on 08/20/2025.
Max Levchin, CEO and director of Affirm Holdings, Inc. (AFRM), reported transactions on 08/18/2025. The filing shows an acquisition and a contemporaneous sale of 14,953 Class A common shares effected under a Rule 10b5-1 trading plan adopted March 17, 2025. The shares were acquired via exercise of performance-based stock options at an exercise price of $49.00 and sold at a weighted average price of $80.05 per share, resulting in no direct Class A shares owned following the sale. The reporting person discloses indirect ownership of 735,294 Class A shares held by the Levchin 2012 Irrevocable Trust and states that, as of 08/20/2025, 4,000,000 stock options have been earned and are vested from a multi-year Value Creation Award. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Form 144 notice for proposed sale of securities by an insider. The filing reports an offer to sell 11,405 shares of common stock on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $897,801.60. The shares represent a tiny fraction of the issuer's outstanding common stock (reported as 281,825,613 shares). The securities were acquired and are proposed to be sold on 08/18/2025 following an exercise of stock options, with payment described as cash. The form also discloses prior 10b5-1 sales of 19,802 shares on 07/07/2025 yielding $1,386,709.24. The signer represents no undisclosed material adverse information and references Rule 10b5-1 procedures.
Form 144 filed for Affirm Holdings, Inc. (AFRM) reporting a proposed sale of 10,800 common shares valued at $850,176.00 to be sold on 08/18/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing shows the shares were acquired and paid for the same day, 08/18/2025, by exercise of stock options from the issuer with payment in cash. The form indicates no securities sold in the past three months by the reporting person. The submission contact and some issuer identification fields are present as form placeholders; the filing includes the standard signature and representation regarding material nonpublic information and Rule 10b5-1 plan disclosure.
Affirm Holdings (AFRM) filed a Form 144 reporting a proposed sale of 333,333 shares of Class A common stock through J.P. Morgan Securities LLC on 08/18/2025 for an aggregate market value of $26,666,640. The filing shows the shares were acquired the same day by stock option exercise and paid in cash; the filing lists 281,825,613 shares outstanding, and notes no securities sold by the holder in the past three months. The filer makes the standard representation that they are not aware of any undisclosed material adverse information. The notice supplies broker, quantity, acquisition method, payment type, and planned sale date but contains no commentary on intent beyond the required certification.
FAQ
What is the current stock price of Affirm Holdings (AFRM)?
What is the market cap of Affirm Holdings (AFRM)?
